127 related articles for article (PubMed ID: 8301049)
1. Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation.
Poo JL; Feldmann G; Moreau A; Gaudin C; Lebrec D
J Hepatol; 1993 Aug; 19(1):90-4. PubMed ID: 8301049
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat.
Poo JL; Feldmann G; Erlinger S; Braillon A; Gaudin C; Dumont M; Lebrec D
Gastroenterology; 1992 May; 102(5):1752-9. PubMed ID: 1568585
[TBL] [Abstract][Full Text] [Related]
3. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation.
Oberti F; Pilette C; Rifflet H; Maïga MY; Moreau A; Gallois Y; Girault A; le Bouil A; Le Jeune JJ; Saumet JL; Feldmann G; Calès P
J Hepatol; 1997 Jun; 26(6):1363-71. PubMed ID: 9210625
[TBL] [Abstract][Full Text] [Related]
4. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
Fernández M; Pizcueta P; García-Pagán JC; Feu F; Cirera I; Bosch J; Rodés J
Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
[TBL] [Abstract][Full Text] [Related]
5. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
[TBL] [Abstract][Full Text] [Related]
6. Prevention of portal hypertension by propranolol and spironolactone in rats with bile duct ligation.
Oberti F; Rifflet H; Maïga MY; Pilette C; Gallois Y; Douay O; Le Jeune JJ; Saumet JL; Calès P
J Hepatol; 1997 Jan; 26(1):167-73. PubMed ID: 9148008
[TBL] [Abstract][Full Text] [Related]
7. Bilioenteric anastomosis reverses hyperkinetic circulation in bile duct-ligated cirrhotic rats.
Jalink D; Urbanski SJ; Lee SS
J Hepatol; 1996 Dec; 25(6):924-31. PubMed ID: 9007722
[TBL] [Abstract][Full Text] [Related]
8. Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution.
Hsu SJ; Tsai MH; Chang CC; Hsieh YH; Huang HC; Lee FY; Chuang CL; Hou MC; Lee SD
Clin Sci (Lond); 2018 Mar; 132(6):669-683. PubMed ID: 29449343
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium.
Lee SS; Girod C; Braillon A; Hadengue A; Lebrec D
Am J Physiol; 1986 Aug; 251(2 Pt 1):G176-80. PubMed ID: 3740260
[TBL] [Abstract][Full Text] [Related]
10. Long-term administration of PGE1 increases liver fibrosis and collateral blood flow in bile-duct-ligated rats.
Fort J; Pilette C; Oberti F; Veal N; Gallois Y; Douay O; Calès P
J Hepatol; 1999 Jan; 30(1):70-6. PubMed ID: 9927152
[TBL] [Abstract][Full Text] [Related]
11. Chronic bile duct ligation in the dog: hemodynamic characterization of a portal hypertensive model.
Bosch J; Enriquez R; Groszmann RJ; Storer EH
Hepatology; 1983; 3(6):1002-7. PubMed ID: 6629314
[TBL] [Abstract][Full Text] [Related]
12. Effects of ursodeoxycholic acid on hemodynamic and renal function abnormalities induced by obstructive jaundice in rats.
Poo JL; Estanes A; Pedraza-Chaverrí J; Cruz C; Uribe M
Ren Fail; 1995 Jan; 17(1):13-20. PubMed ID: 7770639
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension.
Croquet V; Moal F; Veal N; Wang J; Oberti F; Roux J; Vuillemin E; Gallois Y; Douay O; Chappard D; Calès P
J Hepatol; 2002 Dec; 37(6):773-80. PubMed ID: 12445418
[TBL] [Abstract][Full Text] [Related]
14. Experimental colitis in rats with portal hypertension and liver disease.
Ackerman Z; Karmeli F; Cohen P; Rachmilewitz D
Inflamm Bowel Dis; 2003 Jan; 9(1):18-24. PubMed ID: 12656133
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents.
Kageyama Y; Ikeda H; Watanabe N; Nagamine M; Kusumoto Y; Yashiro M; Satoh Y; Shimosawa T; Shinozaki K; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Yokota H; Koyama T; Ishimaru K; Okamoto Y; Takuwa Y; Koike K; Yatomi Y
Hepatology; 2012 Oct; 56(4):1427-38. PubMed ID: 22505286
[TBL] [Abstract][Full Text] [Related]
16. Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis.
Fortea JI; Zipprich A; Fernandez-Mena C; Puerto M; Bosoi CR; Almagro J; Hollenbach M; Bañares J; Rodríguez-Sánchez B; Cercenado E; Clément MA; Rose CF; Bañares R; Vaquero J; Ripoll C
Liver Int; 2018 Jan; 38(1):102-112. PubMed ID: 28665498
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of Salvia miltiorrhiza on cirrhotic rats.
Huang YT; Lee TY; Lin HC; Chou TY; Yang YY; Hong CY
Can J Physiol Pharmacol; 2001 Jul; 79(7):566-72. PubMed ID: 11478589
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic features of advanced cirrhosis due to chronic bile duct ligation.
Katsuta Y; Zhang XJ; Ohsuga M; Akimoto T; Komeichi H; Shimizu S; Inami T; Miyamoto A; Satomura K; Takano T
J Nippon Med Sch; 2005 Aug; 72(4):217-25. PubMed ID: 16113492
[TBL] [Abstract][Full Text] [Related]
19. Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats.
Pun CK; Huang HC; Chang CC; Chuang CL; Yen CH; Hsu SJ; Lee FY; Hou MC; Huang YH
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299285
[TBL] [Abstract][Full Text] [Related]
20. Capsaicin treatment blocks development of hyperkinetic circulation in portal hypertensive and cirrhotic rats.
Lee SS; Sharkey KA
Am J Physiol; 1993 May; 264(5 Pt 1):G868-73. PubMed ID: 8498513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]